Package Insert (PI) Table

Please note the following when using Package Inserts from this web site:

The drug labels and other drug-specific information on this website represent the most recent drug listing information that companies have provided to, or which is obtainable by, the Division of AIDS, NIAID, NIH (“DAIDS”), and are made available here in support of DAIDS-funded and/or -sponsored clinical trials, both domestic and international.   The drug labeling, and other information is as obtainable by DAIDS and its content has neither been altered nor verified by DAIDS; as such, this content may not be Section 508 compliant.  If in the use of adaptive equipment, you encounter problems accessing the content, DAIDS will assist access through equivalent facilitation.  Please e-mail DAIDSRSCwebsitesupport@tech-res.com for assistance.

Drugs

Drug Name Drug Company PI Date Risk List Available?
Dasatinib - New - New Bristol Myers Squibb July 2024
Glecaprevir and Pibrentasvir (Mavyret) - New - New AbbVie October 2023
Isoniazid - New - New Macleods Pharmaceuticals Ltd March 2023
Rifapentine Macleods Pharmaceuticals Ltd July 2024
Progesterone Xiromed, LLC February 2024
Estradiol gel Xiromed, LLC February 2024
Pramipexole Dihydrochloride Dr. Reddy's Laboratories Limited August 2021
Escitalopram Oxalate Cipla USA Inc. September 2023
Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy) - New - New Gilead Sciences October 2024
Cabotegravir and Rilpivirine (Cabenuva) - New - New ViiV Healthcare April 2025
Cabotegravir (Vocabria) ViiV Healthcare December 2023
Ethambutol Macleods Pharmaceuticals Limited July 2019
Estradiol - New - New Epic Pharma LLC January 2025
Rifampicin/Isoniazid Macleods Pharmaceuticals Ltd November 2018
Rifampicin Macleods Pharmaceuticals Ltd November 2018
Rifampicin/Isoniazid Macleods Pharmaceuticals Ltd September 2017
Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir Mylan Laboratories Limited July 2017
Moxifloxacin (Lonxave) Macleods Pharmaceuticals May 2020
Moxifloxacin (Avelox) Bayer May 2020
Doravirine (Pifeltro) - New - New Merck November 2024